DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM PAR
Total 13F shares
4,959,760
Share change
-261,949
Total reported value
$3,942,564
Price per share
$0.80
Number of holders
19
Value change
-$224,686
Number of buys
6
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q4 2020

As of 31 Dec 2020, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,959,760 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, Fan Yu, CITADEL ADVISORS LLC, TWO SIGMA ADVISERS, LP, and Raymond James Financial Services Advisors, Inc.. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.